Info

Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become the gold standard in psychopharmacological clinical trials. Clinical Insights is a site in the NIMH CATIE / Schizophrenia Trials Network. Our Principal Investigator, Lawrence W. Adler, MD, CPI, has participated in the conduct of numerous clinical trials in psychiatric disorders since 1987. We have conducted clinical trials in a variety of psychiatric areas including depression, bipolar disorder, anxiety disorders, panic disorder, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), psychosis, schizophrenia, tardive dyskinesia, Alzheimer's disease, dementia, premenstrual dysphoric disorder (PMDD), migraine, and alcohol dependence. Patients who qualify for research studies receive the following at no cost to the patient or the patient's insurance company:Psychiatric evaluationsMedical examinationsLaboratory assessmentsStudy medicationClinical Insights accepts referrals from any source. Transportation will be provided for patients who require assistance.